-
Good Practice on the assessment of GMO-related aspects in the context of clinical trials with human cells genetically modified by means of viral vectors v5 15-09-2023 Good Practice on the assessment of GMO-related aspects in the context of clinical trials with human cells genetically modified by means of viral vectors v5 PDF | 471.66 kB
-
Common Application form for clinical research with human cells genetically modified by means of viral vectors v5 15-09-2023 Common Application form for clinical research with human cells genetically modified by means of viral vectors v5 DOCX | 30.3 kB
-
-
Gestandaardiseerde MRB VOV gm cellen zonder viruspartikels 23-02-2021 Gestandaardiseerde MRB VOV gm cellen zonder viruspartikels PDF | 455.4 kB
-
Aanvraagformulier VOV gm cellen art 39c 2021-09 v1.0 EN 01-02-2021 Aanvraagformulier VOV gm cellen art 39c 2021-09 v1.0 EN DOCX | 45.48 kB
-
2020-07-23 Guidance document viral vectors - Netherlands_V2.1 10-12-2019 2020-07-23 Guidance document viral vectors - Netherlands_V2.1 PDF | 311.38 kB
-
2020-07-23 Guidance document AAV vectors - Netherlands _V1.1 10-12-2019 2020-07-23 Guidance document AAV vectors - Netherlands _V1.1 PDF | 281.42 kB
-
2019-10-14 Kamerbrief Medische toepassingen biotechnologie 25-10-2019 2019-10-14 Kamerbrief Medische toepassingen biotechnologie PDF | 83.22 kB